Table 3.
Comparison between patients with metastatic and nonmetastatic inoperable gastric adenocarcinoma based on indicators of nutritional and inflammatory status.
| Metastatic | Nonmetastatic$ | Mean difference (95% CI) | P value | |
|---|---|---|---|---|
| BMI∗ | 21.94 ± 3.94 | 22.13 ± 4.11 | 0.18 (−2.43 to 2.81) | 0.885 |
| Albumin∗ | 3.57 ± 0.74 | 3.94 ± 0.68 | 0.36 (−0.30 to 0.76) | 0.070 |
| Prealbumin∗ | 0.14 ± 0.06 | 0.20 ± 0.10 | 0.06 (0.01 to 0.09) | 0.012 |
| Transferrin∗ | 218.48 ± 119.68 | 279.07 ± 135.75 | 60.59 (−5.75 to 126.94) | 0.073 |
| CRP∗∗ | 37.60 (15.59–85.16) | 15.61 (5.52–30.01) | 0.004 | |
| TLC∗ | 1.18 ± 0.49 | 1.27 ± 0.54 | 0.09 (−0.19 to 0.37) | 0.516 |
| PG-SGA∗∗ | 17 (13–20.50) | 17 (11–19) | 0.564 | 0.564 |
∗Mean ± SD, P value based on independent-samples t-test.
∗∗Median (percentiles 25–75), P value based on Mann-Whitney test (only P value was reported).
$Unresectable gastric cancer.